Aspen Aerogels (NYSE: ASPN) reported Q1 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $23.1 million versus the consensus estimate of $24.28 million.

GUIDANCE:

Aspen Aerogels sees Q2 2018 EPS of ($0.74)-($0.87), versus the consensus of ($0.80). Aspen Aerogels sees Q2 2018 revenue of $106-116 million, versus the consensus of $111.9 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.